Magnesium Sulfate Injection, Solution
Product Images NDC 47335-992

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Magnesium Sulfate (NDC 47335-992). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-magsulfate-label-100ml (Spl Mag Sulfate Label 100ml)

Spl-magsulfate-label-100ml (Spl Mag Sulfate Label 100ml)
This is a description of a medication named "Magnesium Sulfate in Water for Injection". It is a sterile, nonpyrogenic solution intended for intravenous infusion. The solution comes in a single-dose container which contains magnesium sulfate heptahydrate and may also contain sulfuric acid and/or sodium hydroxide for pH adjustment. It is not meant to be used with any supplementary medication and should only be used through the central route when possible. The solution should be used promptly after opening the pouch and should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The bag in which the solution comes is free from natural rubber latex, PVG or DEHP. The medication is distributed by Sun Pharmaceutical Industries, Inc. The lot and batch of the product can be found in the unvarnished area.*
FDA Label Image

Spl-magsulfate-label-50ml (Spl Mag Sulfate Label 50ml)

Spl-magsulfate-label-50ml (Spl Mag Sulfate Label 50ml)
This is a description of a single-dose container of Magnesium Sulfate in Water for Injection, containing 2g of magnesium sulfate heptahydrate in 50 mL of water for injection. Sulfuric acid and/or sodium hydroxide may be present for pH adjustment. The solution is sterile and nonpyrogenic and is intended for intravenous infusion. The bag should not be used in series connections, and supplementary medication should not be added. The bag does not contain natural rubber latex, PVC, or DEHP. The bag should be used promptly after opening and stored at 20° to 25°C (68° to 77°F). It is distributed by SO Sun Pharmaceutical Industries and manufactured by Gland Pharma Limited in India. No Batch Details are included in the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.